Abstract: The present invention refers to a method to identify a genetic fusion associated with a subject affected by a disease, preferably B-cell acute lymphoblastic leukemia (B-ALL). A method to classify a subject affected by a disease into a known subtype of said disease and methods to select a suitable therapeutic treatment involving the identification of genetic fusions in said subject are also disclosed.
Type:
Application
Filed:
June 10, 2021
Publication date:
August 3, 2023
Applicant:
ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI "DINO AMADORI" - IRST IRCCS